Skip to main content
Produced by W2D1 Media. Work with us →

About Anton Jackson-Smith

Anton Jackson-Smith is the New Zealand-born chief technology officer of b.next, a synthetic biology company building living cells from scratch rather than modifying organisms such as E. coli. He took an unconventional path from self-taught software engineer in Queenstown to law student at the University of Otago to a PhD in bioengineering at Stanford. Through b.next's open-source Nucleus platform, he is working to make biology programmable, with applications spanning cancer diagnostics and treatment, lab-grown food and smart crops. He discussed the work on Diaspora NZ with David Booth, covering synthetic cells, programmable biology and the future of biotech.

In conversation.

1 episode

Go straight to the good bits.

Key moments from S3 | E6 Anton Jackson Smith (Founder of b.next) on building synthetic cells, programmable biology, and the future of biotech.

  1. 1:21What is a synthetic cell—and why should you care?
  2. 6:44How Anton fell into biology (thanks to an E. coli article in Vietnam)
  3. 11:12Why modifying real cells isn’t enough—and what BNext is doing differently
  4. 16:30The near-term use cases: cancer, diagnostics, and food
  5. 22:47How Nucleus is creating the open-source toolkit for biology
  6. 30:14Three phases of BNext’s business model: Boot → Build → Bazaar
  7. 37:10The big vision: programmable biology that saves lives
  8. 44:18What New Zealand’s biotech future could look like
  9. 47:30Returning talent, building bridges, and bringing brains back home

In their own words.

“Imagine if you built a car and every time you took it out of the garage, something had changed just overnight. That's biology right now.”
Anton Jackson-Smith — S3 | E6 Anton Jackson Smith (Founder of b.next) on building synthetic cells, programmable biology, and the future of biotechDiaspora NZ with David Booth · 11 April 2025

The path so far.

  1. Now

    Chief Technology Officer · b.next

  2. Earlier

    Co-founder · Build-a-Cell

Sources: bnext.bio

b.next on Day One

b.next is a San Francisco biotechnology company developing the tools and infrastructure to build synthetic cells from scratch.

1 person · 1 episode
b.next

Across the network.

Spot something wrong? Suggest a correctionUpdated 29 October 2026

Put your brand alongside the voices founders, investors and operators come to hear.

Explore sponsorship

One useful lesson,
once a month.

Get conversations and practical lessons from the founders, investors and operators on Day One.

Free. Unsubscribe anytime.

Produced by W2D1 Media

Want a show of your own?

W2D1 Media — the team behind the Day One Network, which helped build Blackbird Ventures' Wild Hearts — builds and produces podcasts for funds, founders and operators. If you want a show built around your brand, let's talk.

Start a show →